Should clinicians follow the K/DOQI guidelines for treating hyperphosphatemia with sevelamer?

Nat Clin Pract Nephrol. 2007 Aug;3(8):418-9. doi: 10.1038/ncpneph0536. Epub 2007 Jun 12.

Authors

Hirotaka Komaba¹, Masafumi Fukagawa

Affiliation

¹ Division of Nephrology and Kidney Center, Kobe University School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan.

PMID: 17563773
DOI: 10.1038/ncpneph0536

No abstract available

Publication types

Comment